All sponsors

Sarepta Therapeutics, Inc. $SRPT

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-18
ACTIVE TRIALS5
PHASE 3 / 2-33
RECRUITING0
READOUTS ≤12 MONTHS2
READOUT SLIPPED >6 MO80%

Delay Index: of 5 active trials registered more than a year ago, 4 have moved their primary completion (readout) date by more than 6 months since first registration (median +15.9 months). See all sponsors →

Open Sarepta Therapeutics, Inc. on the live radar map → 📅 $SRPT readout calendar (.ics)
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
EMERGENE
NCT06246513
P3Active, not recruitingLimb-girdle Muscular Dystrophy172025-03-04 (+1 mo)
SRP-1003 IV Infusion
NCT06138743
P1/2Enrolling by invitationMyotonic Dystrophy 1782026-12-31 (+15 mo)
ENVISION
NCT05881408
P3Active, not recruitingDuchenne Muscular Dystrophy1482027-05-31 (+16 mo)
SRP-1001 for Injection
NCT06131983
P1/2Enrolling by invitationMuscular Dystrophy, Facioscapulohumeral602028-12-31 (+45 mo)
EXPEDITION
NCT05967351
P3Enrolling by invitationDuchenne Muscular Dystrophy4002033-10-31 (+35 mo)